Search Advanced

Mathematical Biosciences and Engineering

2015, Volume 12, Issue 6: 1219-1235. doi: 10.3934/mbe.2015.12.1219
Previous Article Next Article

An integrated cellular and sub-cellular model of cancer chemotherapy and therapies that target cell survival

  • 1.
    Department of Applied Mathematics, Brown University, 182 George Street, Providence, RI 02906
  • 2.
    Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109
  • 3.
    Department of Mathematics, University of Michigan, 530 Church Street, Ann Arbor, MI 48109-1043
  • Received: 01 October 2014 Accepted: 29 June 2018 Published: 01 August 2015

  • MSC : Primary: 92C37, 92C50; Secondary: 92C45.

  • Apoptosis resistance is a hallmark of human cancer, and tumor cells often become resistant due to defects in the programmed cell death machinery.Targeting key apoptosis regulators to overcome apoptotic resistance and promote rapid death of tumor cells is an exciting new strategy for cancer treatment, either alone or in combination with traditionally used anti-cancer drugs that target cell division. Here we present a multiscale modeling framework for investigating the synergism between traditional chemotherapy and targeted therapies aimed at critical regulators of apoptosis.

    Citation: Alexis B. Cook, Daniel R. Ziazadeh, Jianfeng Lu, Trachette L. Jackson. An integrated cellular and sub-cellular model of cancer chemotherapy and therapies that target cell survival[J]. Mathematical Biosciences and Engineering, 2015, 12(6): 1219-1235. doi: 10.3934/mbe.2015.12.1219

    Related Papers:

    [1] Rujing Zhao, Xiulan Lai . Evolutionary analysis of replicator dynamics about anti-cancer combination therapy. Mathematical Biosciences and Engineering, 2023, 20(1): 656-682. doi: 10.3934/mbe.2023030
    [2] Abeer S. Alnahdi, Muhammad Idrees . Nonlinear dynamics of estrogen receptor-positive breast cancer integrating experimental data: A novel spatial modeling approach. Mathematical Biosciences and Engineering, 2023, 20(12): 21163-21185. doi: 10.3934/mbe.2023936
    [3] Urszula Ledzewicz, Heinz Schättler, Mostafa Reisi Gahrooi, Siamak Mahmoudian Dehkordi . On the MTD paradigm and optimal control for multi-drug cancer chemotherapy. Mathematical Biosciences and Engineering, 2013, 10(3): 803-819. doi: 10.3934/mbe.2013.10.803
    [4] Yi Liu, Long Cheng, Xiangyang Song, Chao Li, Jiantao Zhang, Lei Wang . A TP53-associated immune prognostic signature for the prediction of the overall survival and therapeutic responses in pancreatic cancer. Mathematical Biosciences and Engineering, 2022, 19(1): 191-208. doi: 10.3934/mbe.2022010
    [5] Samantha L Elliott, Emek Kose, Allison L Lewis, Anna E Steinfeld, Elizabeth A Zollinger . Modeling the stem cell hypothesis: Investigating the effects of cancer stem cells and TGF−β on tumor growth. Mathematical Biosciences and Engineering, 2019, 16(6): 7177-7194. doi: 10.3934/mbe.2019360
    [6] Hongli Yang, Jinzhi Lei . A mathematical model of chromosome recombination-induced drug resistance in cancer therapy. Mathematical Biosciences and Engineering, 2019, 16(6): 7098-7111. doi: 10.3934/mbe.2019356
    [7] Baba Issa Camara, Houda Mokrani, Evans K. Afenya . Mathematical modeling of glioma therapy using oncolytic viruses. Mathematical Biosciences and Engineering, 2013, 10(3): 565-578. doi: 10.3934/mbe.2013.10.565
    [8] Farinaz Forouzannia, Sivabal Sivaloganathan, Mohammad Kohandel . A mathematical study of the impact of cell plasticity on tumour control probability. Mathematical Biosciences and Engineering, 2020, 17(5): 5250-5266. doi: 10.3934/mbe.2020284
    [9] Cassidy K. Buhler, Rebecca S. Terry, Kathryn G. Link, Frederick R. Adler . Do mechanisms matter? Comparing cancer treatment strategies across mathematical models and outcome objectives. Mathematical Biosciences and Engineering, 2021, 18(5): 6305-6327. doi: 10.3934/mbe.2021315
    [10] Erin N. Bodine, K. Lars Monia . A proton therapy model using discrete difference equations with an example of treating hepatocellular carcinoma. Mathematical Biosciences and Engineering, 2017, 14(4): 881-899. doi: 10.3934/mbe.2017047
  • Apoptosis resistance is a hallmark of human cancer, and tumor cells often become resistant due to defects in the programmed cell death machinery.Targeting key apoptosis regulators to overcome apoptotic resistance and promote rapid death of tumor cells is an exciting new strategy for cancer treatment, either alone or in combination with traditionally used anti-cancer drugs that target cell division. Here we present a multiscale modeling framework for investigating the synergism between traditional chemotherapy and targeted therapies aimed at critical regulators of apoptosis.


    [1] Science, 281 (1998), 1322-1326.
    [2] PLoS One, 9 (2014), e99404.
    [3] Nature, 415 (2002), 922-926.
    [4] Oncogene, 27 (2009), S128-S136.
    [5] Annu. Rev. Immunol., 16 (1998), 395-419.
    [6] J. Biol. Chem., 269 (1994), 787-790.
    [7] Neoplasia, 5 (2003), 161-169.
    [8] Cancers, 3 (2011), 1351-1371.
    [9] Ann NY Acad Sci, 1010 (2003), 153-158.
    [10] Mol. Pharmacol., 59 (2001), 657-663.
    [11] PLoS One, 9 (2014), e81582.
    [12] Cancer Res., 71 (2011), 705-715.
    [13] Mol. Cancer There., 8 (2009), 2926-2936.
    [14] Bull. Math. Biol., 70 (2008), 89-117.
    [15] J Neurochem, 84 (2003), 273-281.
    [16] Chem. Rev., 107 (2007), 1387-1407.
    [17] J. Biol. Chem., 286 (2011), 14564-14574.
    [18] Clin. Cancer Res., 9 (2003), 4287-4295.
    [19] J. Exp Clin. Cancer Res., 31 (2012), p102.
    [20] Mol. Cell., 6 (2000), 1389-1399.
    [21] Mol. Cancer Ther., 8 (2009), 10-16.
    [22] Cancers, 3 (2011), 415-427.
    [23] Adv Studies in Biol, 4 (2012), 19-25.
    [24] Int. J. Oncol., 29 (2006), 471-479.
    [25] Nature, 407 (2000), 810-816.
    [26] Cancer Res., 73 (2013), 5485-5496.
    [27] Oncologist, 15 (2010), 994-1001.
    [28] Nat. Rev. Drug Discov., 1 (2002), 111-121.
    [29] Adv. in Pharm., 41 (1997), 501-532.
    [30] J. Clin. Oncol., 30 (2012), 488-496.
    [31] Clin. Cancer Res., 1 (1995), 981-989.
    [32] JNCI., 82 (1990), 749-755.
    [33] Adv. Cancer Res., 108 (2010), 73-112.
    [34] Hemotol., 1 (2005), 226-230.
    [35] Ind. Eng. Chem. Res., 50 (2011), 12872-12880.
    [36] Chem. Res. Toxicol., 17 (2004), 1434-1444.
    [37] Eur. J. Cancer, 28 (1992), 82-86.
    [38] Cancer Res., 68 (2008), 3421-3428.
    [39] Scient, 292 (2001), 727-730.

  • This article has been cited by:

    1. Fuli Wang, Rongxiang Zhang, Yong Cui, Liping Sheng, Yinping Sun, Wei Tian, Xiao Liu, Shuzeng Liang, Design, synthesis and biological evaluation of 3,4-dihydronaphthalen-1(2H)-one derivatives as Bcl-2 inhibitors, 2017, 43, 0922-6168, 5933, 10.1007/s11164-017-2972-x
    2. Ning Li, Wen-Yu Xin, Bin-Rong Yao, Chun-Hua Wang, Wei Cong, Feng Zhao, Hong-Juan Li, Yun Hou, Qing-Guo Meng, Gui-Ge Hou, Novel dissymmetric 3,5-bis(arylidene)-4-piperidones as potential antitumor agents with biological evaluation in vitro and in vivo, 2018, 147, 02235234, 21, 10.1016/j.ejmech.2018.01.088
    3. Ning Li, Binrong Yao, Chunhua Wang, Qingguo Meng, Guige Hou, Synthesis, crystal structure and activity evaluation of novel 3,4-dihydro-1-benzoxepin-5(2H)-one derivatives as protein–tyrosine kinase (PTK) inhibitors, 2017, 73, 2053-2296, 1003, 10.1107/S2053229617015145
    4. Binrong Yao, Ning Li, Chunhua Wang, Guige Hou, Qingguo Meng, Ke Yan, Novel asymmetric 3,5-bis(arylidene)piperidin-4-one derivatives: synthesis, crystal structures and cytotoxicity, 2018, 74, 2053-2296, 659, 10.1107/S2053229618006605
    5. Fereshteh Nazari, Alexandra E. Oklejas, Jacques E. Nör, Alexander T. Pearson, Trachette L. Jackson, In Silico Models Accurately Predict In Vivo Response for IL6 Blockade in Head and Neck Cancer, 2020, 80, 0008-5472, 1451, 10.1158/0008-5472.CAN-19-1846
    6. Michelle Przedborski, David Sharon, Steven Chan, Mohammad Kohandel, A mean-field approach for modeling the propagation of perturbations in biochemical reaction networks, 2021, 165, 09280987, 105919, 10.1016/j.ejps.2021.105919
  • Reader Comments
  • © 2015 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Mathematical Biosciences and Engineering
4.4

Metrics

Article views(2718) PDF downloads(517) Cited by(6)

Preview PDF
Download XML
Export Citation
Article outline
Abstract
References

Other Articles By Authors

Related pages

Tools

Copyright © AIMS Press

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog